Vow published an operational update for Q1 yesterday (the company reports semi-annually).
Redeye remains confident that OXE Marine is on the right track.
Sparekassen Sjælland-Fyn's Q1 2022 earnings were negatively impacted by market value adjustments and...
Netcompany delivered a Q1 close to company-compiled consensus and solid 13% organic revenue growth, ...
Etteplan is quite confident it can achieve healthy sales growth and stable margins for the rest of t...
Cibus's Q1 2022 income from property management (IFPM) was largely in line with Infront consensus.
Q1 should be similar to Q4, with strong growth Short-term risks driven by external environment.
Sales miss, but very strong order intake of SEK 482m Most of the orders are planned to be delivered ...
Duearity publicerade idag den 5 maj sin kvartalsrapport för årets första kvartal 2022.
De senaste två åren har varit utmanande för såväl landbaserade kasinon som deras underleverantörer, ...
Sammanfattning av Q1'22 publicerad Loudsprings Q1'22 medförde inga betydande nyheter då de största h...
Idag lämnade Medclair sin rapport för det första kvartalet 2022 med en nettoomsättning på 7,7 miljon...
Regardless of geopolitical tensions and COVID-19 related sickness absences, Etteplan reported a good...
Our concerns for a softer Q1 were clearly unfounded, as Etteplan's net sales grew 23% to EUR 89.
Redeye considers I-Tech’s Q1-figures overall in line with estimates.
Suominen’s Q1 results and guidance downgrade weren’t that big negatives in our view, however there’s...
Q1 profitability fell short of expectations and Eltel also removed guidance due to inflation.
Pihlajalinna’s Q1 revenue came in 4% above estimates and helped profitability land some EUR 3m highe...
Q1 2022 PBLL came in DKK 31 (21%) below our estimate, mainly led by a DKK 25m miss on low quality ma...
Redeye leaves its view on Xbrane Biopharma following today’s Q1, confirming that a BLA submission to...
